Effects of atorvastatin (and blood pressure lowering comparing amlodipide-based therapy with beta-blocker-based therapy) on serum variables of cholesterol synthesis and absorption, thrombogenicity and on low-density lipoprotein oxidation in vivo.
Nieminen
M S
MS
Department of Medicine, Division of Cardiology, Helsinki University Hospital, Haartmaininkatu 4, 00290 Helsinki, Finland.
Viikari
J
J
Ahotupa
M
M
Vasankari
T
T
Kantola
I
I
Strandberg
T
T
Vanhanen
H
H
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D001794:Blood Pressure / Q000187:drug effects; D002784:Cholesterol / Q000378:metabolism; D003327:Coronary Disease / Q000517:prevention & control*; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D008077:Lipoproteins, LDL / Q000187:drug effects* / Q000378:metabolism; D010084:Oxidation-Reduction; D011758:Pyrroles / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use; D013927:Thrombosis / Q000517:prevention & control; D014280:Triglycerides / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D008077:Lipoproteins, LDL; D011758:Pyrroles; D013565:Sympatholytics; D014280:Triglycerides; D002784:Cholesterol; D000069059:Atorvastatin